| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,896,273 | 1,583,545 | 1,368,198 | 1,656,739 | | Cost of Revenue | 1,815,390 | 1,481,011 | 1,180,153 | 1,580,594 | | | Gross Profit | 80,883 | 102,534 | 188,045 | 76,145 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 24,756 | 30,378 | 35,122 | 54,849 | | Non Recurring | 9,047 | 299,552 |
-
|
-
| | Others | 34,725 | 40,417 | 34,240 | 31,044 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 21,402 | (267,813) | 118,683 | (9,748) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (748) | (7,561) | (151) | 19,441 | | Earnings Before Interest And Taxes | 6,775 | (275,374) | 118,532 | 9,693 | | Interest Expense | 20,940 | 38,498 | 28,609 | 33,919 | | Income Before Tax | (14,165) | (313,872) | 89,923 | (24,226) | | Income Tax Expense | (9,383) | (6,555) | 30,995 | (11,397) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,782) | (307,317) | 58,928 | (12,829) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,782) | (307,317) | 58,928 | (12,829) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,782) | ($307,317) | $58,928 | ($12,829) |
|
0.02% Nasdaq 
0.11 (2.37%) 
Income Statement
